Aimee draws on more than 15 years of experience as a medical writer and journalist to direct Speaking of Science’s content and creative strategy. She drives each project at Speaking of Science from conception to completion, working shoulder to shoulder with clients to ensure each one is executed flawlessly and delivered seamlessly.
Throughout her career, Aimee’s health-sector expertise has expanded across multiple therapeutic areas, including oncology, cardiovascular health, immunology, and diabetes. She has a personal interest in precision medicine and molecularly-informed clinical research.
Prior to founding Speaking of Science, Aimee provided communication expertise to leading biopharma, medical research, health tech, and consumer genomic companies, writing about real-world evidence for Pfizer, adherence for Novartis and Sanofi, patient engagement for the MMRF, and NGS for Illumina. She has written for The Washington Post, The Atlantic, New York and other top-tier media outlets, sparking conversations around some of today’s most vexing scientific quandaries.
